SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDevolver Dig. S Regulatory News (DEVO)

Share Price Information for Devolver Dig. S (DEVO)

Share Price is delayed by 15 minutes
Get Live Data
21.00    0.00 (0.00%)
Bid:
20.00
Ask:
22.00
Spread: 2.00 (10.00%)
Market Cap: £101.95m
DEVO Live PriceLast checked at - London Stock Exchange

Intraday Devolver Dig. S Share Chart

Trading Update

3 Aug 2023 07:00

RNS Number : 1383I
Devolver Digital, Inc.
03 August 2023
 

3 August 2023

The information contained within this announcement is deemed by the company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014 as it forms part of the domestic law of the United Kingdom by virtue of the European Union (Withdrawal) Act 2018 (as amended) ("UK MAR"). Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.

 

 

Devolver Digital, Inc. 

("Devolver Digital", "Devolver" or the "Company", and the Company together with all of its subsidiary undertakings "the Devolver Group")

Trading Update

Devolver Digital, an award-winning digital publisher and developer of indie video games, announces a trading update for the six months to 30 June 2023, and updated guidance for the current financial year ending 31 December 2023.

Our expectation for performance for 2023 has been impacted by three key factors: delays to new title releases, a reduction in revenue from subscription deals and a lower contribution from our back-catalogue.

Our strategy is to maximise the appeal and success of new titles by increasing investment in development, quality control and marketing. While critical to our long-term growth, prioritising quality to meet the standards and performance expected of Devolver titles is resulting in delays, higher costs and greater complexity for new releases. As such The Plucky Squire, a title that has been tracking well with audiences, will now be released in 2024. It joins other titles previously earmarked for release in 2023, such as Anger Foot, Pepper Grinder and Stick It to the Stickman, which were flagged earlier in 2023 as delayed in order to continue value-add production to further improve their chances of success and longevity. Devolver released one major title in 1H 2023, the award-winning Terra Nil. In the second half of 2023, we expect to release Wizard with a Gun and The Talos Principle 2, as well as other titles in Q4 2023.

After a period of strong contribution during COVID, we have turned down some subscription deal proposals in 2023 that we felt did not adequately recognise the value of our titles. While subscription deals with key platforms remain a part of our long-term growth strategy, the management team has declined several weaker propositions from major platform partners as we felt they undervalued the proposed games' value and revenue opportunity in 2023 and 2024. We expect this trend of reduced revenues from subscription deals to continue in 2024, compared to the period of heightened subscription revenues in 2021 and 2022.

Back-catalogue sales have been softer following the weaker performance of three key title releases in 2022, except for Cult of the Lamb which has continued to perform strongly. As highlighted earlier in 2023, a weaker overall economic environment continues to soften back-catalogue momentum year-to-date.

In light of the performance year-to-date we expect Normalised Adjusted EBITDA1 to be negative in the first half of 2023. For the full year ending 31 December 2023, we now expect Group Normalised Adjusted EBITDA to be at least break-even. The Board expects Normalised Adjusted EBITDA to return to growth in 2024 and accelerate in 2025.

Devolver has a robust balance sheet with c.US$64m net cash on hand as at end June 2023, which takes into account a c.US$7m purchase of shares in the market in 1H 2023, which are now held in Devolver's Employee Benefit Trust.

Devolver will provide further details on trading in its half year results announcement, which is expected to be released in September 2023.

 

 Harry Miller, Executive Chairman of Devolver Digital, said:

 

"We are disappointed that 2023 performance will be lower than expected, as we see an impact from delays to new titles, fewer subscription deals and weaker back-catalogue revenues. We want to ensure that we invest the right amount of time, effort and money into our titles as the best way to do justice to our healthy pipeline of releases scheduled for the next 24 months. We continue to look for ways to improve our return from the back-catalogue, as well as taking the right steps to maximise revenues from our new releases.

 

We have seen a strong showing for upcoming Devolver titles at the PlayStation Showcase 2023 in May, and have secured exciting longer-term title wins such as Human Fall Flat 2. We are focusing on our programme to translate the benefits of greater scale and quality into improved revenues and margins beyond 2023, expecting a return to growth in 2024 and 2025. As we work towards these long-term goals, we will pursue a capital allocation strategy that reflects our faith in the long-term strategy of the business. We look forward to updating the market on our progress in the coming months."

 

-ENDS-

Notes

1. Normalised adjusted EBITDA excludes: 1) stock compensation (share-based payment) expenses and revaluation of contingent consideration; 2) one-time expenses and other non-recurring items; 3) amortisation of IP (but does not exclude amortisation of capitalised software development costs), and; 4) impairments of goodwill, acquired IP and cancelled, unreleased games. Normalised adjusted EBITDA does include impairments of capitalised software development costs of underperforming released games.

 

About Devolver Digital

  

Devolver is an award-winning video games publisher in the indie games space with a balanced portfolio of third-party and own-IP. Devolver has an emphasis on premium games and has published more than 100 titles, with more than 30 titles in the pipeline scheduled for release over the next few years. Devolver has in-house studios developing first-party IP titles and a complementary publishing brand. Devolver is registered in Wilmington, Delaware, USA. 

 

Enquiries

 

Devolver Digital, Inc.

ir@devolverdigital.com  

Harry Miller, Executive Chairman   

Douglas Morin, Chief Executive Officer

Daniel Widdicombe, Chief Financial Officer

Zeus (Nominated Adviser and Sole Broker)

+44 (0)20 3829 5000

Nick Cowles, Jamie Peel, Alexander Craig (Investment Banking)

Ben Robertson (Equity Capital Markets

FTI Consulting (Communications Adviser)

devolver@fticonsulting.com 

Jamie Ricketts/ Dwight Burden/ Valerija Cymbal/ Usama Ali

+44 (0)20 3727 1000

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTPTMBTMTJMTBJ
12
Date   Source Headline
4th Jun 20265:00 pmRNSNotice of Annual Meeting
3rd Jun 202612:29 pmRNSBlock Listing Return
15th Apr 20269:00 amRNSPublication of 2025 Annual Report and Accounts
9th Apr 20267:00 amRNSUnaudited preliminary results
30th Mar 202611:03 amRNSInvestor Presentation via Investor Meet Company
30th Mar 20267:00 amRNSNotice of Results
30th Mar 20267:00 amRNSBoard Change
9th Feb 20267:00 amRNSTrading Update
2nd Feb 20267:00 amRNSBlock Listing Application
30th Dec 20254:30 pmRNSTotal Voting Rights
30th Dec 20254:30 pmRNSTotal Voting Rights
15th Dec 20257:00 amRNSGrant of Awards
18th Nov 20257:00 amRNSBlock Listing Return
29th Oct 20257:00 amRNSGrant of Awards and PDMR Dealing
24th Oct 20254:30 pmRNSResult of Special Meeting
7th Oct 20257:00 amRNSNotice of Special Meeting
29th Sep 20257:00 amRNSHalf Year Results
8th Sep 20257:00 amRNSNotice of Half Year Results
27th Jun 20254:20 pmRNSResult of AGM
27th Jun 20257:00 amRNSTrading Statement
5th Jun 20256:03 pmRNSNotice of Annual Meeting
19th May 20257:00 amRNSBlock Listing Return
15th Apr 20257:00 amRNSPublication of 2024 Annual Report and Accounts
10th Apr 20257:00 amRNSUnaudited preliminary results
19th Mar 20257:00 amRNSNotice of Results
4th Feb 20257:00 amRNSTrading Update
30th Jan 20257:00 amRNSTR-1: Notification of Major Holdings
4th Dec 20244:30 pmRNSTransfer of Treasury Shares & Total Voting Rights
19th Nov 20247:00 amRNSBlock Listing Return
9th Oct 20247:00 amRNSGrant of Awards
26th Sep 20247:00 amRNSHalf Year Results
9th Sep 20247:00 amRNSNotice of Full Year Results
23rd Jul 20247:00 amRNSAppointment of Joint Broker
5th Jul 20249:25 amRNSTR-1: Notification of Major Holdings
5th Jul 20249:23 amRNSTR-1: Notification of Major Holdings
2nd Jul 20247:00 amRNSResults of Placing
1st Jul 20244:35 pmRNSProposed placing via accelerated bookbuild
28th Jun 20246:04 pmRNSResult of AGM
28th Jun 20247:00 amRNSTrading Statement
19th Jun 20241:00 pmRNSNotice of Annual Meeting
30th May 202412:13 pmRNSBlock Listing Return
22nd Apr 20245:00 pmRNSPublication of 2023 Annual Report and Accounts
18th Apr 20247:00 amRNSUnaudited preliminary results
13th Mar 20247:00 amRNSNotice of Full Year Results
31st Jan 20247:01 amRNSBoard and Leadership Change
31st Jan 20247:00 amRNSTrading Update
6th Dec 20237:00 amRNSGrant of Awards
1st Nov 20237:00 amRNSACQUISITION OF SYSTEM ERA SOFTWORKS, INC
25th Sep 20237:00 amRNSHalf Year Results
15th Sep 20237:00 amRNSNotice of Results
12

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.